[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Cutting Edge SAS\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":88},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,40,65],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":5},"100550418","multicentric-clinical-investigation-to-assess-safety-and-performance-of-lux-highadd-iol-100550418",false,"NCT06446817","Multicentric Clinical Investigation to Assess Safety and Performance of Lux HighAdd IOL","Multicentric Clinical Investigation to Determine Safety and Efficacy of a Hydrophobic Acrylic Multifocal Intraocular Lens","HIGHADD","Inclusion Criteria:\n\n* Subject aged 50 or over on the day of inclusion, presenting a bilateral cataract, qualified for bilateral implantation\n* No ocular comorbidity possibly affecting the study results\n* Fit within the available IOL diopter range\n* Have had no previous refractive surgery\n* Regular corneal astigmatism ≤1.0 dioptres\n* Clear intraocular media other than cataract\n* Availability, willingness and sufficient cognitive awareness to comply with examination procedures\n* Ability to attend all study follow-ups\n* Signed informed consent.\n\nExclusion Criteria:\n\n* Ocular surface disease potentially affecting study results\n* Pre-existing ocular pathology or history of pathology potentially affecting the study results\n* Acute or chronic disease or illness that would increase risk or confound study results\n* Subjects who may be reasonably expected to require a secondary surgical intervention at any time during the investigation (other than YAG capsulotomy)\n* Axial lengths and keratometry such as the IOL spherical power is not in the range of 16 to 26 D\n* Instability of keratometry or biometry measurements\n* Traumatic cataract\n* Amblyopia\n* History of ocular trauma or any prior ocular surgery including refractive procedures\n* Capsular or zonular abnormalities that may affect postoperative centration or tilt of the lens\n* Pupil abnormalities\n* Systemic or ocular medication that could modify pupil dynamics\n* Expected complicated surgery or complicated surgery\n* Concurrent participation in another drug or device investigation","ALL","50 Years",{"count":20,"type":21},57,"ESTIMATED","INTERVENTIONAL",[24],"NA","The study purpose is to demonstrate safety and performance of bilateral implantation of LuxHighAdd intraocular lens compared with the LuxGood Monofocal lens.",[27],"Cataract","RECRUITING","2026-05-21",{"date":31,"type":32},"2026-05-26","ACTUAL",{"date":34,"type":32},"2024-12-19",{"date":36,"type":21},"2028-12",{"name":38,"class":39},"Cutting Edge SAS","INDUSTRY",{"id":41,"slug":42,"hasResults":11,"nctId":43,"briefTitle":44,"officialTitle":45,"acronym":46,"eligibilityCriteria":47,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":48,"targetDuration":4,"studyType":22,"phases":50,"briefSummary":51,"conditions":52,"keywords":54,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":56,"lastUpdatePostDateStruct":57,"startDateStruct":59,"completionDateStruct":61,"leadSponsor":63,"locationsCount":64},"100535967","bicentric-clinical-investigation-to-assess-safety-and-performance-of-luxboost-iol-100535967","NCT06258707","Bicentric Clinical Investigation to Assess Safety and Performance of LuxBoost IOL","Bicentric Clinical Investigation to Assess Safety and Performance of a Hydrophobic Acrylic Enhanced Monofocal Intraocular Lens.","LuxBoost","Inclusion Criteria:\n\n* Subject aged 50 or over on the day of inclusion, presenting a\n* bilateral cataract for which posterior chamber IOL implantation\n* has been planned.\n* Fit within the available IOL diopter range.\n* Have had no previous refractive surgery.\n* Regular corneal astigmatism \\\u003C 1 dioptre by an automatic\n* keratometer (regularity measured by topographer).\n* Availability, willingness, and sufficient cognitive awareness to\n* comply with examination procedures.\n* Ability to attend all study follow-ups.\n* Signed informed consent.\n\nExclusion Criteria:\n\n* Ocular surface disease potentially affecting study results\n* Subjects suffering from diagnosed degenerative visual disorders\n* Pre-existing ocular pathology\n* Acute or chronic disease or illness that would increase risk or confound study results\n* Axial lengths and keratometry such as the IOL spherical power is\n* not in the range of 14 to 28 D\n* Instability of keratometry or biometry measurements\n* Amblyopia\n* History of ocular trauma or any prior ocular surgery including refractive procedures\n* Capsular or zonular abnormalities that may affect postoperative centration or tilt of the lens",{"count":49,"type":21},58,[24],"The study purpose is to demonstrate safety and performance of bilateral implantation of LuxBoost intraocular lenses compared with the LuxGood Monofocal lens.",[53],"Aphakia",[55],"Enhanced monofocal IOL","2026-02-11",{"date":58,"type":32},"2026-02-12",{"date":60,"type":32},"2024-10-14",{"date":62,"type":21},"2027-06-15",{"name":38,"class":39},2,{"id":66,"slug":67,"hasResults":11,"nctId":68,"briefTitle":69,"officialTitle":69,"acronym":70,"eligibilityCriteria":71,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":72,"targetDuration":4,"studyType":74,"phases":4,"briefSummary":75,"conditions":76,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":79,"lastUpdatePostDateStruct":80,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":87},"100482395","comparison-of-visual-outcomes-after-implantation-of-the-synthesis-plus-and-synthesis-plus-toric-100482395","NCT05561478","Comparison of Visual Outcomes After Implantation of the Synthesis Plus and Synthesis Plus Toric","DETPLUST","Inclusion Criteria:\n\n* Patient older than 50 years old\n* Patient requiring bilateral cataract surgery\n* Regular corneal astigmatism \\>0.5D measured by MS-39 (SimK keratometry and regularity determined by the topography) for patients implanted with SYNTHESIS PLUS TORIC or Regular corneal astigmatism lower or equal to 0.5 D dioptres by MS-39 (SimK keratometry and regularity determined by the topography) for patients implanted with SYNTHESIS PLUS.\n* Expected postoperative astigmatism ≤ 0.75D diopter\n* Corneal astigmatism ≤4D\n* IOL spherical equivalent power requested between 15D and 25D\n* Signed informed consent\n* Availability, willingness and sufficient cognitive awareness to comply with examination procedures\n\nNon inclusion Criteria:\n\n* Patients with a potential postoperative visual acuity of less than 5\u002F10, in particular due to degenerative visual disorders, poor retinal function or a damaged cornea.\n* Amblyopia with a visual acuity potential of less than 5\u002F10\n* IOL power needed outside the spherical equivalent diopter range: 15 to 25D\n* Difficulty for cooperation (distance from their home, general health condition)\n* Acute or chronic disease or illness that would increase risk or confound study results (e.g. diabetes mellitus (with retinopathy), immunocompromised, glaucoma etc…)\n* Irregular astigmatism\n* Subject with postoperative astigmatism, expected \\> 0.75 D.\n* Any ocular comorbidity\n* History of ocular trauma or prior ocular surgery including refractive procedures\n* Capsule or zonular abnormalities that may affect postoperative centration or tilt of the lens (e.g. pseudoexfoliation syndrome, chronic Uveitis, Marfan's syndrome)\n* Patients with chronic uveitis\n* Pupil abnormalitis (non-reactive, tonic pupils, abnormally shaped pupils or pupils that do not dilate under mesopic\u002Fscotopic conditions, diameter (pupil\\>4mm or \\\u003C2.5 mm in photopic conditions))\n* Narrow anterior chambers (ACD ≤ 2.5 mm)\n* Any corneal pathology potentially affecting the topography (eg. Keratoconus),\n* Monophthalma patients\n* Phacodonesis\n\nExclusion criteria:\n\n* Complicated surgery\n* Inability to place the intraocular lens safely at the location planned\n* Subjects with zonular laxity\n* Postoperative endophthalmitis",{"count":73,"type":21},72,"OBSERVATIONAL","Prospective controlled monocentric study to determine the non-inferiority of the distance-corrected intermediate visual acuity at 66 cm of the SYNTHESIS PLUS TORIC with respect to the SYNTHESIS PLUS IOL.",[27,77,78],"Surgery","IOL","2025-02-10",{"date":81,"type":32},"2025-02-11",{"date":83,"type":32},"2022-10-10",{"date":85,"type":21},"2025-10",{"name":38,"class":39},1,""]